Mehyar Nimer, Alhajeri Ziyad, Alosaimi Muath, Alanazi Ziyad, Alanazi Abdulkarim, Abusaris Raghib
College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia.
King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
Front Clin Diabetes Healthc. 2025 Jul 29;6:1617641. doi: 10.3389/fcdhc.2025.1617641. eCollection 2025.
Increasing evidence shows that hyperglycemia-induced glucotoxicity and lipotoxicity that usually accompany diabetes development damage the endoplasmic reticulum and mitochondria of the hepatocytes in diabetic patients. Clinical studies highlighted the association between type 2 diabetes mellitus, comorbidities, and medications with liver function. The objective of this study is to explore the association between liver function tests' abnormalities and comorbidities, medications, and other risk factors in type 2 diabetes patients registered in the Best-Care system of the Saudi Ministry of National Guard-Health Affairs.
This is a cross-sectional study employing a chart of patients diagnosed with type 2 diabetes mellitus. We drew a simple random sample of 523 T2DM patients who had a liver function test from the Best-Care database of the Ministry. We applied various statistical analyses, including Student's independent t-test, Pearson's chi-squared test, Fisher's exact test, and odd ratios, to measure associations between different variables and liver function tests' abnormalities.
About 35% of patients included in this study showed an abnormal level of gamma-glutamyl transferase and prothrombin time. Abnormalities of serum albumin, prothrombin time, and total serum protein tests were significantly associated with age (P < 0.05). Gamma-glutamyl transferase test abnormalities were significantly associated with gender (P < 0.05). The study found associations between several comorbidities and the abnormalities of liver function tests. These tests include the total bilirubin, albumin, total serum protein, gamma-glutamyl trans, international normalized ratio, and alanine aminotransferase. The associations were at significant levels (P < 0.05). Liraglutide was significantly associated with aspartate aminotransferase (OR = 14.40, 95% CI = 2.8, 73.2), while allopurinol was significantly associated with international normalized ratios (OR = 24.67, 95% CI = 2.95, 206.58) and total serum protein (OR = 5.44, 95% CI = 1.43, 20.83).
This study is the first to examine the association between type 2 diabetes mellitus and liver function tests' abnormalities in Saudi Arabia. Although the results have a limited generalizability due to inherent biases, the findings align with similar studies in other populations. The study stresses the need to monitor liver functions, especially of T2DM patients who suffer from other conditions.
越来越多的证据表明,通常伴随糖尿病发展的高血糖诱导的糖毒性和脂毒性会损害糖尿病患者肝细胞的内质网和线粒体。临床研究强调了2型糖尿病、合并症以及药物与肝功能之间的关联。本研究的目的是探讨沙特国民卫队卫生事务部最佳护理系统中登记的2型糖尿病患者肝功能检查异常与合并症、药物及其他风险因素之间的关联。
这是一项采用2型糖尿病患者病历的横断面研究。我们从该部的最佳护理数据库中抽取了523例进行过肝功能检查的2型糖尿病患者的简单随机样本。我们应用了各种统计分析方法,包括学生独立t检验、皮尔逊卡方检验、费舍尔精确检验和比值比,以测量不同变量与肝功能检查异常之间的关联。
本研究中约35%的患者γ-谷氨酰转移酶和凝血酶原时间水平异常。血清白蛋白、凝血酶原时间和总血清蛋白检查异常与年龄显著相关(P<0.05)。γ-谷氨酰转移酶检查异常与性别显著相关(P<0.05)。该研究发现几种合并症与肝功能检查异常之间存在关联。这些检查包括总胆红素、白蛋白、总血清蛋白、γ-谷氨酰转移酶、国际标准化比值和丙氨酸氨基转移酶。这些关联具有显著水平(P<0.05)。利拉鲁肽与天冬氨酸氨基转移酶显著相关(比值比=14.40,95%置信区间=2.8,73.2),而别嘌醇与国际标准化比值(比值比=24.67,95%置信区间=2.95,206.58)和总血清蛋白(比值比=5.44,95%置信区间=1.43,20.83)显著相关。
本研究首次在沙特阿拉伯考察2型糖尿病与肝功能检查异常之间的关联。尽管由于内在偏倚,结果的普遍适用性有限,但研究结果与其他人群的类似研究一致。该研究强调需要监测肝功能,尤其是患有其他疾病的2型糖尿病患者的肝功能。